Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Pharma Mar SA ( (ES:PHM) ).
Pharma Mar S.A. has provided details of its recent share buyback program, which took place from February 10 to 14, 2025. The transactions were conducted on the BME trading center, with a total of 7,563 shares repurchased at varying weighted average prices. This buyback program is a strategic move to stabilize the company’s stock price and potentially enhance shareholder value.
More about Pharma Mar SA
Pharma Mar S.A. operates in the biotechnology industry, focusing on the development and commercialization of cancer treatment drugs derived from marine organisms.
YTD Price Performance: 25.95%
Average Trading Volume: 1,486
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.84B
Learn more about PHM stock on TipRanks’ Stock Analysis page.